Slingshot members are tracking this event:
GlycoMimetics to Present New Preclinical Data on GMI-1359 Dual Antagonist
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Apr 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Preclinical Data, Gmi-1359, Anti-tumor Activity, Pancreatic Cancer, Acute Myeloid Leukemia